23andMe to Buy Telehealth Firm Lemonaid for $400M

2023 insurance M&As lowest in a decade

Direct-to-consumer DNA testing firm 23andMe Holding Co said on Friday it would buy privately held company Lemonaid Health Inc for $400 million in a cash-and-stock deal, as it looks to expand into telemedicine. Lemonaid Health offers patients direct online access for a number of common conditions, from consultation through treatment. It also offers free and… Continue reading 23andMe to Buy Telehealth Firm Lemonaid for $400M